documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

18,238 rows where agency_id = "FDA", document_type = "Other" and posted_year = 2017 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 2017 · 18,238 ✖

document_type 1

  • Other · 18,238 ✖

agency_id 1

  • FDA · 18,238 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-V-7020-0002 FDA FDA-2017-V-7020 Acknowledgment Letter from FDA DDM to W6 Restaurant Group LTD Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:38:57Z   0 0 0900006482d83ab8
FDA-2017-H-6960-0001 FDA FDA-2017-H-6960 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:59:43Z   0 0 0900006482d84c25
FDA-2017-H-6973-0001 FDA FDA-2017-H-6973 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T19:30:07Z   0 0 0900006482d84ca5
FDA-2017-V-7020-0001 FDA FDA-2017-V-7020 Variance Application from W6 Restaurant Group LTD Other Application for Variance (VAR) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:38:51Z   0 0 0900006482d83ab6
FDA-2017-P-7031-0002 FDA FDA-2017-P-7031 Acknowledgment Letter from FDA DDM to JRRapoza Associates, Inc Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T17:34:05Z   0 0 0900006482d8388f
FDA-2017-P-7032-0001 FDA FDA-2017-P-7032 Citizen Petition from Jubilant Generics Limited Other Citizen Petition 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z 2018-06-28T03:59:59Z 2018-01-02T16:48:06Z   0 0 0900006482d843bf
FDA-2017-V-7023-0001 FDA FDA-2017-V-7023 Variance Application from Platinum AVL Other Application for Variance (VAR) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:37:20Z   0 0 0900006482d83c59
FDA-1977-N-0025-0007 FDA Internal, Analgesic, Antipyretic & Antirheumatic Drug Products - OPEN FDA-1977-N-0025 Supplement from Wyeth Consumer Healthcare Other Supplement (SUP) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2019-02-01T15:40:00Z   0 0 09000064805da2f9
FDA-2017-H-6986-0001 FDA FDA-2017-H-6986 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T20:05:43Z   0 0 0900006482d85162
FDA-2017-V-7021-0002 FDA FDA-2017-V-7021 Acknowledgment Letter from FDA DDM to Trio Nightclub Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:41:48Z   0 0 0900006482d83abe
FDA-2014-P-0646-0011 FDA FDA-2014-P-0646 Letter from Kamat Pharmatech to FDA DDM Other Letter(s) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:42:48Z   0 0 0900006482d8388b
FDA-2017-P-7032-0002 FDA FDA-2017-P-7032 Acknowledgment Letter from FDA DDM to Jubilant Generics Limited Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2018-01-02T16:48:30Z   0 0 0900006482d843c1
FDA-2017-H-6948-0001 FDA FDA-2017-H-6948 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:48:22Z   0 0 0900006482d84e08
FDA-2017-P-7033-0001 FDA FDA-2017-P-7033 Citizen Petition from Jubliant Generics Limited Other Citizen Petition 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z 2018-06-28T03:59:59Z 2018-01-02T16:50:17Z   0 0 0900006482d84d79
FDA-2017-H-6958-0001 FDA FDA-2017-H-6958 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:54:54Z   0 0 0900006482d84e3e
FDA-2017-H-6952-0001 FDA FDA-2017-H-6952 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:47:45Z   0 0 0900006482d84e02
FDA-2017-D-6530-0002 FDA FDA-2017-D-6530 Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industry DRAFT GUIDANCE Other Guidance 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z 2018-03-30T03:59:59Z 2024-11-07T01:15:37Z   1 0 0900006482d7eb25
FDA-2017-D-6564-0002 FDA FDA-2017-D-6564 Best Practices for Communication Between IND Sponsors and FDA During Drug Development Guidance for Industry and Review Staff Other Guidance 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2024-11-07T01:15:37Z   1 0 0900006482d7eb23
FDA-2017-P-7033-0002 FDA FDA-2017-P-7033 Acknowledgment Letter from FDA DDM to Jubilant Generics Limited Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2018-01-02T16:50:45Z   0 0 0900006482d84da4
FDA-2017-P-7034-0001 FDA FDA-2017-P-7034 Citizen Petition from Jubilant Generics Limited Other Citizen Petition 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z 2018-06-28T03:59:59Z 2018-01-02T16:52:40Z   0 0 0900006482d84d2a
FDA-2017-P-7031-0001 FDA FDA-2017-P-7031 Citizen Petition from JRRapoza Associates, Inc Other Citizen Petition 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z 2018-06-28T03:59:59Z 2017-12-29T17:33:49Z   0 0 0900006482d8388d
FDA-2016-N-0832-0057 FDA FDA-2016-N-0832 Letter from Phibro Animal Health Corporation Other Letter(s) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T15:57:53Z   0 0 0900006482d83a18
FDA-2017-V-7023-0002 FDA FDA-2017-V-7023 Acknowledgement Letter from FDA DDM to Platinum AVL Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:37:25Z   0 0 0900006482d83c5c
FDA-2017-V-7028-0002 FDA FDA-2017-V-7028 Acknowledgement Letter from FDA DDM to Richard Nguyen Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:19:48Z   0 0 0900006482d84abf
FDA-2017-H-6963-0001 FDA FDA-2017-H-6963 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T19:24:17Z   0 0 0900006482d84efa
FDA-2017-P-7034-0002 FDA FDA-2017-P-7034 Acknowledgment Letter from FDA DDM to Jubilant Generics Limited Other Acknowledgement Letter/Receipt 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2018-01-02T16:53:05Z   0 0 0900006482d84d2c
FDA-2017-H-6953-0001 FDA FDA-2017-H-6953 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:45:41Z   0 0 0900006482d84e38
FDA-2017-V-7021-0001 FDA FDA-2017-V-7021 Variance Application from Trio Nightclub Other Application for Variance (VAR) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T16:41:43Z   0 0 0900006482d83abc
FDA-2017-V-7028-0001 FDA FDA-2017-V-7028 Variance Application from RICHARD NGUYEN Other Application for Variance (VAR) 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T18:19:42Z   0 0 0900006482d837cd
FDA-2017-H-6972-0001 FDA FDA-2017-H-6972 Complaint Other Complaint 2017-12-29T05:00:00Z 2017 12 2017-12-29T05:00:00Z   2017-12-29T19:11:59Z   0 0 0900006482d84ef4
FDA-1980-N-0038-0138 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Certain Topical Anti-Infective Drug Products; Vioform-Hydrocortisone (Iodochlorhydroxyquin and Hydrocortisone) Request of CIBA-GEIGY Corporation for Hearing Vol I re: Supplement from CIBA-GEIGY (Wald, Harkrader & Ross) (Vol 1 of 3) Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:11:59Z   0 0 09000064805b963e
FDA-2017-P-4039-0003 FDA FDA-2017-P-4039 Interim Response Letter from FDA CDER to Center for Lawful Access and Abuse Deterrence Other Letter(s) 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T21:28:04Z   0 0 0900006482d7f298
FDA-2015-V-0429-0003 FDA FDA-2015-V-0429 Approval Letter from FDA CDRH to Power Technology, Inc. Other Approval for Variance (VRA) 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T15:21:49Z   0 0 0900006482d7b398
FDA-2017-H-6956-0001 FDA FDA-2017-H-6956 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T15:55:12Z   0 0 0900006482d7b912
FDA-2017-H-6957-0001 FDA FDA-2017-H-6957 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T18:31:50Z   0 0 0900006482d7c0f5
FDA-2017-H-6954-0001 FDA FDA-2017-H-6954 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T15:25:41Z   0 0 0900006482d7b39a
FDA-2017-H-6962-0001 FDA FDA-2017-H-6962 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T19:21:49Z   0 0 0900006482d7db54
FDA-2005-D-0140-0010 FDA Guidance for Industry: Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry;' FDA-2005-D-0140 Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry: Guidance for Industry Other Guidance 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2024-11-07T01:15:24Z   1 0 0900006482d7ee3c
FDA-2017-H-6965-0001 FDA FDA-2017-H-6965 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T19:25:13Z   0 0 0900006482d7e13f
FDA-1980-N-0038-0156 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Request for Hearing from Clay-Park Labs, Inc. Other Request for Hearing 2017-12-28T05:00:00Z 2017 12     2017-12-28T19:23:17Z   0 0 09000064805b964a
FDA-1980-N-0038-0141 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Letter from Miles Laboratories, Inc. to FDA/DDM Other Letter(s) 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:13:51Z   0 0 09000064805b963f
FDA-1980-N-0038-0153 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Answer Letter from Arthur Hull Hayes, Jr. to American Academy of Dermatology, Inc. Other Answer 2017-12-28T05:00:00Z 2017 12     2017-12-28T19:21:20Z   0 0 09000064805b9647
FDA-1980-N-0038-0155 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Letter from Linda M. Quinones to American Academy of Dermatology, Inc. Other Letter(s) 2017-12-28T05:00:00Z 2017 12     2017-12-28T19:22:12Z   0 0 09000064805b9649
FDA-1980-N-0038-0148 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Burroughs Wellcome Co. (Vol. 1 of 5) Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2020-01-31T06:55:40Z   0 0 09000064805b9646
FDA-1980-N-0038-0133 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Merck Sharp & Dohme Research Labs (Vol. 1 of 4) Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:05:18Z   0 0 09000064805b963c
FDA-1980-N-0038-0142 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Withdrawal Letter from Miles Laboratories, Inc. Other Withdrawal 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:19:41Z   0 0 09000064805b9640
FDA-2017-H-6964-0001 FDA FDA-2017-H-6964 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T19:23:34Z   0 0 0900006482d7db87
FDA-2017-V-6985-0001 FDA FDA-2017-V-6985 Variance Application from Aka Booking Agency Other Application for Variance (VAR) 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T15:15:52Z   0 0 0900006482d73063
FDA-2017-H-6966-0001 FDA FDA-2017-H-6966 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T19:32:32Z   0 0 0900006482d7e147
FDA-1980-N-0038-0147 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Mayrand, Inc. Pharmaceuticals Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2020-01-31T06:55:39Z   0 0 09000064805b9645
FDA-1980-N-0038-0145 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from UAD Laboratories, Inc. Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2020-01-31T06:55:40Z   0 0 09000064805b9643
FDA-1980-N-0038-0119 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from National Pharmaceutical Alliance Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:02:14Z   0 0 09000064805b962f
FDA-1980-N-0038-0143 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Correction from the Lemmon Company Other Correction(s) 2017-12-28T05:00:00Z 2017 12     2018-01-02T20:45:08Z   0 0 09000064805b9641
FDA-1980-N-0038-0137 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 The Proposal to Withdraw the New Drug Application for Terra-Cortril Topical Ointment (NDA 61-011, Section 446.567(a)) - Submission of Data for Terra-Cortril Topical Ointment re Supplement from Pfizer Inc. Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2017-12-28T18:11:19Z   0 0 09000064805b963d
FDA-1980-N-0038-0144 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Marnel Pharmaceuticals, Inc. Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2020-01-31T07:27:06Z   0 0 09000064805b9642
FDA-1980-N-0038-0146 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Dermik Laboratories, Inc. Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2020-01-31T06:55:40Z   0 0 09000064805b9644
FDA-1980-N-0038-0154 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Amendment from BYK-Gulden, Inc. (Covington & Burling) Other Amendment 2017-12-28T05:00:00Z 2017 12     2017-12-28T19:21:07Z   0 0 09000064805b9648
FDA-2017-V-6985-0002 FDA FDA-2017-V-6985 Acknowledgement Letter from FDA DDM to AKA Booking Agency Other Acknowledgement Letter/Receipt 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T15:15:57Z   0 0 0900006482d73066
FDA-2017-H-6951-0001 FDA FDA-2017-H-6951 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T18:19:30Z   0 0 0900006482d7c150
FDA-2017-V-4971-0003 FDA FDA-2017-V-4971 Response Letter from FDA CDRH to Charles Gardner Other Agency Response 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T18:12:31Z   0 0 0900006482d7c89e
FDA-1980-N-0038-0157 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Syntex Laboratories (Kleinfeld, Kaplan and Becker) Other Supplement (SUP) 2017-12-28T05:00:00Z 2017 12     2017-12-28T19:24:45Z   0 0 09000064805b964b
FDA-2014-V-2139-0003 FDA FDA-2014-V-2139 Approval Letter from FDA DDM to Laserdock Limited Other Approval for Variance (VRA) 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T18:20:46Z   0 0 0900006482d7c8a0
FDA-2017-H-6961-0001 FDA FDA-2017-H-6961 Complaint Other Complaint 2017-12-28T05:00:00Z 2017 12 2017-12-28T05:00:00Z   2017-12-28T18:33:17Z   0 0 0900006482d7c7a2
FDA-2017-D-6784-0002 FDA FDA-2017-D-6784 Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers Draft Guidance for Industry Other Guidance 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z 2018-03-28T03:59:59Z 2024-11-07T01:15:33Z   1 0 0900006482d77d2d
FDA-1980-N-0038-0117 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from E. R. Squibbs & Sons (Vol. 1 of 2) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2017-12-27T15:18:57Z   0 0 09000064805b962e
FDA-2017-H-6946-0001 FDA FDA-2017-H-6946 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:59:25Z   0 0 0900006482d76e76
FDA-2017-V-4514-0003 FDA FDA-2017-V-4514 Approval Letter from FDA CDRH to Princeton Lightwave, Inc Other Approval for Variance (VRA) 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T21:32:29Z   0 0 0900006482d78a75
FDA-2017-H-6937-0001 FDA FDA-2017-H-6937 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:56:30Z   0 0 0900006482d77270
FDA-2017-H-6945-0001 FDA FDA-2017-H-6945 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:21:10Z   0 0 0900006482d76d5e
FDA-2017-H-6913-0001 FDA FDA-2017-H-6913 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T19:17:29Z   0 0 0900006482d782be
FDA-2017-P-5435-0003 FDA FDA-2017-P-5435 Withdrawal from Hyman, Phelps & McNamara PC Other Withdrawal 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T21:01:16Z   0 0 0900006482d72ce0
FDA-2017-H-6932-0001 FDA FDA-2017-H-6932 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T12:48:34Z   0 0 0900006482d748e1
FDA-2017-H-6938-0001 FDA FDA-2017-H-6938 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T13:29:26Z   0 0 0900006482d761f0
FDA-2017-H-6926-0001 FDA FDA-2017-H-6926 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T13:32:34Z   0 0 0900006482d74189
FDA-1980-N-0038-0113 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Syntex Laboratories, Inc. (Vol. 1 of 3) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2017-12-27T15:19:54Z   0 0 09000064805b962c
FDA-1980-N-0038-0103 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Byk-Gilden, Inc. (Vol. 1 of 2) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2017-12-27T15:20:26Z   0 0 09000064805b9629
FDA-1980-N-0038-0114 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Burroughs Wellcome Co. ( Vol. 1 of 3) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2020-01-31T06:55:41Z   0 0 09000064805b962d
FDA-2017-H-6929-0001 FDA FDA-2017-H-6929 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T12:31:38Z   0 0 0900006482d74016
FDA-2017-H-6950-0001 FDA FDA-2017-H-6950 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:46:57Z   0 0 0900006482d76cc4
FDA-1980-N-0038-0102 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Letter from the Upjohn Company to FDA/DDM Other Letter(s) 2017-12-27T05:00:00Z 2017 12     2017-12-28T17:51:24Z   0 0 09000064805b9627
FDA-2017-H-6916-0001 FDA FDA-2017-H-6916 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T19:42:04Z   0 0 0900006482d78196
FDA-2017-H-6935-0001 FDA FDA-2017-H-6935 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:51:02Z   0 0 0900006482d76cf7
FDA-2017-H-6944-0001 FDA FDA-2017-H-6944 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T14:39:57Z   0 0 0900006482d75e9f
FDA-2017-H-6936-0001 FDA FDA-2017-H-6936 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T15:53:33Z   0 0 0900006482d76d56
FDA-2017-H-6941-0001 FDA FDA-2017-H-6941 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T14:12:22Z   0 0 0900006482d75d94
FDA-2017-H-6930-0001 FDA FDA-2017-H-6930 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T12:39:22Z   0 0 0900006482d748db
FDA-2017-H-6920-0001 FDA FDA-2017-H-6920 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T19:46:59Z   0 0 0900006482d77e08
FDA-1980-N-0038-0105 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Request of Dermik Laboratories, Inc., for Withdrawal of Notice of Opportunity for Hearing and Submission in Support of Request for Hearing (Vol. 1 of 4) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2017-12-27T14:18:28Z   0 0 09000064805b962a
FDA-2017-H-6942-0001 FDA FDA-2017-H-6942 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T14:22:37Z   0 0 0900006482d76bea
FDA-2017-H-6949-0001 FDA FDA-2017-H-6949 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T16:35:58Z   0 0 0900006482d76e04
FDA-2017-H-6947-0001 FDA FDA-2017-H-6947 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T16:34:07Z   0 0 0900006482d76d64
FDA-1980-N-0038-0109 FDA Anti-Infective Drug Products for Dermatologic Use FDA-1980-N-0038 Supplement from Lilly Research Laboratories (Vol. 1 of 2) Other Supplement (SUP) 2017-12-27T05:00:00Z 2017 12     2017-12-27T15:20:05Z   0 0 09000064805b962b
FDA-2017-H-6943-0001 FDA FDA-2017-H-6943 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T14:32:29Z   0 0 0900006482d75e99
FDA-2017-H-6934-0001 FDA FDA-2017-H-6934 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T13:04:18Z   0 0 0900006482d761ea
FDA-2017-V-4545-0003 FDA FDA-2017-V-4545 Approval Letter from FDA CDRH to Foxconn Interconnect Technology Other Approval for Variance (VRA) 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T21:34:34Z   0 0 0900006482d78a78
FDA-2017-H-6933-0001 FDA FDA-2017-H-6933 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T12:56:12Z   0 0 0900006482d75b25
FDA-2017-H-6939-0001 FDA FDA-2017-H-6939 Complaint Other Complaint 2017-12-27T05:00:00Z 2017 12 2017-12-27T05:00:00Z   2017-12-27T14:01:11Z   0 0 0900006482d75d8e
FDA-1998-P-0262-0004 FDA ANADA Suitability for Propofol Anesthetic Injection-CLOSED FDA-1998-P-0262 Internal Memo from FDA CVM to FDA DDM Other Memorandum 2017-12-26T05:00:00Z 2017 12 2017-12-26T05:00:00Z   2024-07-25T15:20:29Z   0 0 0900006480a3e397
FDA-2015-D-1245-0020 FDA FDA-2015-D-1245 Guidance for Industry on Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System Other Guidance 2017-12-26T05:00:00Z 2017 12 2017-12-26T05:00:00Z   2024-11-07T01:16:09Z   1 0 0900006482d734ba
FDA-2017-P-4249-0006 FDA FDA-2017-P-4249 Withdrawal from GE Healthcare Inc Other Withdrawal 2017-12-26T05:00:00Z 2017 12 2017-12-26T05:00:00Z   2017-12-26T18:13:47Z   0 0 0900006482d738a2

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);